ZERBE ROBERT L MD sold 12.3% of their position (3.28K shares) of VERICEL CORP on the open market
Open‑market sale worth $169.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/29/2024ACC: 0001140361-24-016591
+3.28K
Net shares
Net buyer
$169.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.56K acquired · 3.28K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.28K
Price / share
$3.74
Trade value
$12.26K
% of position
14.0%
3/27/2024
23.39K→26.67K
Common Stock
Direct
Shares
−3.28K
Price / share
$51.57
Trade value
$169.05K
% of position
12.3%
3/27/2024
26.67K→23.39K
Total
Net shares
+0.00
Net value
-$156.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/27/2024 | M · Option Exercise | +3.28K | $3.74 | $12.26K | 14.0% | 23.39K | 26.67K |
| Common Stock Direct | 3/27/2024 | S · Sale | −3.28K | $51.57 | $169.05K | 12.3% | 26.67K | 23.39K |
| Total | +0.00 | -$156.79K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
3.28K shares
Shares
+3.28K
Strike price
3.74
Held after
0.00
Exercisable
—
3/27/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock3.28K shares | 3/27/2024 | M · Option Exercise | +3.28K | 3.74 | — | 0.00 |